Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...

The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...

People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...

US hospitals recommend the MEAL plan for patients taking weight loss medications such as Wegovy and Ozempic Learn how this ...

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...

A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic Nineties and beach-body-ready Noughties, the judgement is real. It is ...

IF you’re on a weight loss jab, you’ll have a suppressed appetite and feel full quickly after eating – the ideal recipe for ...

Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...

A once-weekly injection for weight loss known as a ‘GP-1 agonist’. It mimics a hormone in the gut that reduces our desire to eat and controls sugar in the blood. Developed originally for diabetes but ...